Rebecca Dietzen

The meeting included a review of legislative and regulatory updates concerning various assembly bills related to health and safety codes and radiologic practice. The committee held extensive discussions on defining and standardizing continuing education credits for various license holders, resulting in the approval of a proposal for category-specific credit requirements. Additionally, the committee discussed the clinical mammography experience, specifically exploring alternative pathways for certified technologists to obtain necessary mammography certification, and received an informational update on the Radiologic Operation Support Specialist program.

The committee meeting covered updates on personnel changes, including upcoming retirements, and provided an overview of ongoing research projects related to Borrelia sp. R57. Discussions included reports from various vector control agencies regarding tick surveillance and the detection of pathogens. The California Department of Public Health presented progress reports on Lyme disease case surveillance and tick infection prevalence, alongside an update on outreach and education initiatives. A showcase of historical Lyme disease and tick bite prevention resources developed over the past 25 years was presented, followed by reflections on the committee's long-standing contributions to public health awareness.

The meeting agenda includes discussions and potential votes on various legislative items such as training requirements for opioid overdose reversals, a health omnibus bill, hazardous materials and metal shredding facilities, suicide prevention initiatives, Medi-Cal coverage and lactation services, and strategic planning equity. The board will receive reports from the California Department of Public Health on policy and priorities, along with committee updates and affiliate reports covering topics such as chronic disease, communicable disease control, environmental health, health equity, and maternal and child health. Legislative stakeholder updates and future planning discussions are also scheduled.

The Board of Directors meeting agenda focuses on administrative updates, including an Executive Committee summary and the status of emergency medical services legislation (AB 1607). The board will receive reports from the California Department of Public Health regarding policy, priorities, and external relationships. Committee updates and affiliate reports are scheduled for various public health areas, including Chronic Disease and Injury Prevention, Communicable Disease Control and Prevention, Environmental Health, Health Equity, Maternal, Child and Adolescent Health, and Health Systems Integration. Specific action items include addressing legislation regarding Tianeptine (AB 634), Nitrous Oxide sales (SB 936), Hepatitis B and C (AB 1843), and data collection related to sexual orientation, gender identity, and intersex status (SB 1114). Additionally, there will be legislative stakeholder updates and brief reports from volunteer groups and regional health officer groups.

The meeting includes updates from the California Department of Public Health, committee updates from groups focused on areas such as chronic disease, injury prevention, communicable disease control, environmental health, health equity, maternal and child health, and health systems integration. Other agenda items involve legislative stakeholder updates, reports from affiliate organizations, and discussions regarding Title 17 updates for Amatoxin Poisoning reporting and the prohibition of battery-embedded vapor inhalation devices.